Tel Aviv University researchers have discovered that the secreted protein LCN2 facilitates the formation of aggressive brain metastases (secondary cancers). In lab tests, reducing LCN2 in the blood halts the advance of the inflammatory process that causes tumors in the brain.
https://www.jpost.com/health-and-wellness/article-732284